NMDAR AUTOIMMUNE ENCEPHALITIS
Clinical trials for NMDAR AUTOIMMUNE ENCEPHALITIS explained in plain language.
Never miss a new study
Get alerted when new NMDAR AUTOIMMUNE ENCEPHALITIS trials appear
Sign up with your email to follow new studies for NMDAR AUTOIMMUNE ENCEPHALITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets rare 'Brain on Fire' diseases
Disease control Recruiting nowThis study is testing an investigational drug called satralizumab for people with two rare autoimmune brain diseases (NMDAR or LGI1 encephalitis). The goal is to see if the drug helps improve patients' daily function and reduces seizures better than a placebo, while monitoring sa…
Matched conditions: NMDAR AUTOIMMUNE ENCEPHALITIS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Young survivors of rare brain disease face hidden Long-Term struggles
Knowledge-focused Recruiting nowThis study aims to understand the long-term social and psychological challenges faced by young adults who have recovered from the acute phase of a rare autoimmune brain disease called NMDA receptor encephalitis. Researchers will survey 30 adult patients to measure their quality o…
Matched conditions: NMDAR AUTOIMMUNE ENCEPHALITIS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC